<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/alny" ></link>
<id>urn:uuid:a262fa35-f892-d843-57fb-54bf707933f5</id>
<updated>2026-05-03T20:48:18-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ALNY: MCLAUGHLIN MELISSA (HR) Sold (AS) 3,854 Shares of ALNYLAM PHARMACEUTICALS INC for $316.61-$333.94 on 4/2-4/6</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6383039" ></link>
<id>urn:uuid:e9187d9e-dbe9-dd44-40c5-adce858609ce</id>
<updated>2026-04-07T16:21:18-04:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: MCLAUGHLIN MELISSA (HR) Sold (AS) 56 Shares of ALNYLAM PHARMACEUTICALS INC for $320.14 on 4/6</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6383040" ></link>
<id>urn:uuid:bc796f34-2d00-3dfe-e42b-9b3a37cf9856</id>
<updated>2026-04-07T16:21:18-04:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: MCLAUGHLIN MELISSA (HR) Filed a Form 3, Becoming a Registered Insider at ALNYLAM PHARMACEUTICALS INC With Initial Direct Holdings of 13,353</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6382967" ></link>
<id>urn:uuid:2f1fc011-7964-bec1-c1d6-e45db3423a91</id>
<updated>2026-04-07T16:16:36-04:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: GARG PUSHKAL (VP) Sold (AS) 4,713 Shares of ALNYLAM PHARMACEUTICALS INC for $319.03-$326.08 on 3/4-3/5</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6354648" ></link>
<id>urn:uuid:eec1b0c1-5135-ed9d-5074-8a23ff3ecc2d</id>
<updated>2026-03-06T16:13:37-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: GREENSTREET YVONNE (CEO,DIR) Sold (S) 2,933 Shares of ALNYLAM PHARMACEUTICALS INC for $319.03-$325.67 on 3/4</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6354637" ></link>
<id>urn:uuid:c2437749-d1d7-5706-6ad7-7875fc1064bc</id>
<updated>2026-03-06T16:13:11-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: POULTON JEFFREY V (VP,CFO) Sold (S) 2,468 Shares of ALNYLAM PHARMACEUTICALS INC for $319.03-$325.67 on 3/4</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6354628" ></link>
<id>urn:uuid:5659c249-1fda-1ecb-c4ff-064a6474f0b0</id>
<updated>2026-03-06T16:12:42-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: TANGULER TOLGA (VP) Sold (S) 2,309 Shares of ALNYLAM PHARMACEUTICALS INC for $319.03-$325.67 on 3/4</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6354630" ></link>
<id>urn:uuid:86abf6a5-f807-0481-bab1-929175d72fb4</id>
<updated>2026-03-06T16:12:15-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: FITZGERALD KEVIN JOSEPH (VP) Sold (AS) 1,291 Shares of ALNYLAM PHARMACEUTICALS INC for $319.03-$326.24 on 3/4-3/5</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6354635" ></link>
<id>urn:uuid:b2899067-936a-76e7-0314-aacdf8613e4b</id>
<updated>2026-03-06T16:11:49-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: POULTON JEFFREY V (VP,CFO) Acquired (JB) 4,769 Shares of ALNYLAM PHARMACEUTICALS INC for $0.00 on 3/2</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6352471" ></link>
<id>urn:uuid:ef74f733-37b4-5062-e600-e45e88720cdf</id>
<updated>2026-03-04T19:31:44-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>ALNY: POULTON JEFFREY V (VP,CFO) Sold (S) 2,206 Shares of ALNYLAM PHARMACEUTICALS INC for $323.62-$332.64 on 3/2</title>
<link href="http://www.insiderinsights.com/company/alny/alnylam-pharmaceuticals-inc/id-6352472" ></link>
<id>urn:uuid:9f1a961d-39ad-4c1f-3a2f-f48778bf2feb</id>
<updated>2026-03-04T19:31:44-05:00</updated>
<summary type="html" ><![CDATA[ALNYLAM PHARMACEUTICALS INC (ALNY). Recent Price: $310.28. Mkt Cap:41.4B. 10D Vol: 1.1mm]]></summary>
</entry>
</feed>